MBX Biosciences reports positive Phase II data for once-weekly canvuparatide in hypoparathyroidism, highlighting efficacy and safety.
Discover Quince Therapeutics’ breakthrough drug-delivery platform aiming to safely treat rare diseases with encapsulated steroids.
Objectives C reactive protein (CRP) is frequently normal in psoriatic arthritis (PsA) despite active disease, complicating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback